|
See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!
My Account
Join us! · InformexUSA 2012 · New Orleans, Louisiana ·
February 14-17, 2012
· Booth 2514
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Description
(+)WIN 55212-
1 Felder, C.C., Joyce, K.E., Briley, E.M., et al. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol 48 443-450 (1995).
2
Ferraro, L., Tomasini, C., Gessa, G.L., et al. The cannabinoid receptor agonist WIN 55,212-
3
Price, T.J., Patwardhan, A., Akopian, A.N., et al. Cannabinoid receptor-
Background ReadingFelder, C.C., Joyce, K.E., Briley, E.M., et al. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol 48 443-450 (1995). Price, T.J., Patwardhan, A., Akopian, A.N., et al. Cannabinoid receptor- Ferraro, L., Tomasini, C., Gessa, G.L., et al. The cannabinoid receptor agonist WIN 55,212- (+)WIN 55212-2 (mesylate) is available in the following screening libraries:
|
This product is available in custom sizes and/or larger quantities. Please contact our Sales Department for a quote or to purchase. Pricing updated 2012-02-11. Prices are subject to change without notice. To ask for assistance with one of our products please contact a Technical Support Scientist. Warning This product is not for human or veterinary use.
Related ProductsShow all 41 Hide all but first 3Downloads
Batch-specific InformationLogin to access batch-specific information
|
Cayman Chemical is a manufacturer, supplier and vendor of biochemical reagents, assay kits, antibodies, and proteins. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640 Copyright 2012 Cayman Chemical Company | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||